Ifp Advisors, Inc Y M Abs Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 334 shares of YMAB stock, worth $2,842. This represents 0.0% of its overall portfolio holdings.
Number of Shares
334
Previous 0
Infinity%
Holding current value
$2,842
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding YMAB
# of Institutions
101Shares Held
27.2MCall Options Held
38.4KPut Options Held
2.1K-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$36.1 Million0.96% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.24MShares$27.5 Million9.97% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$25 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$18.7 Million0.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$16.6 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $372M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...